What does Apotheek DK do?

Apotheek DK is a pharmacy in Brugge. Public Limited, started on 20 December 1984, 1 establishment.

What is the address of Apotheek DK?

The registered office of Apotheek DK is located at Gistelse Steenweg 131, 8200 Brugge.

Is Apotheek DK still active?

Yes. According to the CBE (31 October 2026) Apotheek DK is active, legal situation “Normale toestand”, started on 20 December 1984.

Is Apotheek DK registered on Peppol?

Yes, Apotheek DK is registered on the Peppol network with ID 0208:0426771294.

What is the enterprise number of Apotheek DK?

The enterprise number of Apotheek DK is BE0426771294.

When was Apotheek DK founded?

Apotheek DK was founded on 20 December 1984.

Who are the directors of Apotheek DK?

According to the 2025 annual accounts, the directors of Apotheek DK are: BRAFO BV.

Is Apotheek DK a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 December 1984; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek DK make in 2025?

Apotheek DK posted a profit after taxes of € 49,942 in financial year 2025.

What is the revenue of Apotheek DK?

As a small company, Apotheek DK is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 238,854.

How much does an employee at Apotheek DK earn?

The average wage cost per full-time employee at Apotheek DK was € 85,500 in 2025: staff costs of € 153,977 for 1.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek DK have?

According to the 2025 annual accounts, Apotheek DK has 1.8 full-time equivalents (FTE).

Does Apotheek DK have a website?

Yes, Apotheek DK has a website at apotheekdk.be.

Apotheek DK (Public Limited) - Brugge - BE0426771294

Dossier Apotheek DK, printed on 31 October 2026 from databakkes.be/en/0426771294/apotheek-dk. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek DK from Brugge, company number BE0426771294, closed financial year 2025 with a result of € 49,942 after tax. For that financial year Apotheek DK recorded a gross margin of € 238,854 and equity of € 239,883. Compared with financial year 2024, the result moved from € 99,932 to € 49,942. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.

What it is worth Growing

€ 239,883

▲ 26% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 49,942

▼ 50% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 33,816

▼ 32% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 170,254.

People and assets in 2025

Full-time equivalents

1.8

▲ 0.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 153,977

▲ 50% vs 2024

€ 85,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 4,214

▲ 98% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 99,538

▲ 225% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 29,688

▲ 59% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 3,535 Gross margin 2022: € 3,535 First fiscal year in the series	€ 114,121 Gross margin 2023: € 114,121 ▲ € 110,586 vs 2022 (€ 3,535) Favourable step	€ 225,367 Gross margin 2024: € 225,367 ▲ 97% vs 2023 (€ 114,121) Favourable step	€ 238,854 Gross margin 2025: € 238,854 ▲ 6% vs 2024 (€ 225,367) Favourable step	▲ 6%
Profit after taxes	€ -11,909 Profit after taxes 2022: € -11,909 First fiscal year in the series	€ 25,375 Profit after taxes 2023: € 25,375 ▲ € 37,284 vs 2022 (€ -11,909) Favourable step	€ 99,932 Profit after taxes 2024: € 99,932 ▲ 294% vs 2023 (€ 25,375) Favourable step	€ 49,942 Profit after taxes 2025: € 49,942 ▼ 50% vs 2024 (€ 99,932) Unfavourable step	▼ 50%
Equity	€ 116,979 Equity 2022: € 116,979 First fiscal year in the series	€ 90,008 Equity 2023: € 90,008 ▼ 23% vs 2022 (€ 116,979) Unfavourable step	€ 189,940 Equity 2024: € 189,940 ▲ 111% vs 2023 (€ 90,008) Favourable step	€ 239,883 Equity 2025: € 239,883 ▲ 26% vs 2024 (€ 189,940) Favourable step	▲ 26%
Total debts	€ 228,642 Total debts 2022: € 228,642 First fiscal year in the series	€ 277,454 Total debts 2023: € 277,454 ▲ 21% vs 2022 (€ 228,642) Unfavourable step	€ 138,016 Total debts 2024: € 138,016 ▼ 50% vs 2023 (€ 277,454) Favourable step	€ 225,564 Total debts 2025: € 225,564 ▲ 63% vs 2024 (€ 138,016) Unfavourable step	▲ 63%
Cash	€ 13,710 Cash 2022: € 13,710 First fiscal year in the series	€ 66,935 Cash 2023: € 66,935 ▲ € 53,225 vs 2022 (€ 13,710) Favourable step	€ 49,763 Cash 2024: € 49,763 ▼ 26% vs 2023 (€ 66,935) Unfavourable step	€ 33,816 Cash 2025: € 33,816 ▼ 32% vs 2024 (€ 49,763) Unfavourable step	▼ 32%
Land & buildings	€ 23,456 Land & buildings 2022: € 23,456 First fiscal year in the series	€ 19,014 Land & buildings 2023: € 19,014 ▼ 19% vs 2022 (€ 23,456) Unchanged	€ 17,084 Land & buildings 2024: € 17,084 ▼ 10% vs 2023 (€ 19,014) Unchanged	€ 15,416 Land & buildings 2025: € 15,416 ▼ 10% vs 2024 (€ 17,084) Unchanged	▼ 10%
Retained profit	€ 55,005 Retained profit 2022: € 55,005 First fiscal year in the series	€ 20,380 Retained profit 2023: € 20,380 ▼ 63% vs 2022 (€ 55,005) Unfavourable step	€ 120,312 Retained profit 2024: € 120,312 ▲ € 99,932 vs 2023 (€ 20,380) Favourable step	€ 170,254 Retained profit 2025: € 170,254 ▲ 42% vs 2024 (€ 120,312) Favourable step	▲ 42%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 60,000 Dividend 2023: € 60,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 60,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 143,011 Bank debt 2022: € 143,011 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 143,011) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 345,621 Balance sheet total 2022: € 345,621 First fiscal year in the series	€ 367,462 Balance sheet total 2023: € 367,462 ▲ 6% vs 2022 (€ 345,621) Unchanged	€ 327,957 Balance sheet total 2024: € 327,957 ▼ 11% vs 2023 (€ 367,462) Unchanged	€ 465,446 Balance sheet total 2025: € 465,446 ▲ 42% vs 2024 (€ 327,957) Unchanged	▲ 42%
Employees (FTE)	-	0.7 Employees (FTE) 2023: 0.7 First fiscal year in the series	1 Employees (FTE) 2024: 1 ▲ 0.3 vs 2023 (0.7) Unchanged	1.8 Employees (FTE) 2025: 1.8 ▲ 0.8 vs 2024 (1) Unchanged	▲ 0.8

Key figures of Apotheek DK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek DK?

What happened at Apotheek DK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 15, 2026 New annual accounts for financial year 2025: profit of € 49,942 (▼ 50% vs 2024). Source: NBB ↗
Dec 20, 1984 New establishment in Brugge. KBO
Dec 20, 1984 Start of the company according to the CBE. KBO

In short

From € 11,909 loss in 2022 to € 49,942 profit in 2025.

Paid € 22,823 in corporate taxes since 2022.

Best year ever: 2024, with € 99,932 profit.

On average € 132,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

BRAFO 90.9%

The stake of BRAFO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek DK

Behind Apotheek DK is BRAFO BV. The shares are held by BRAFO (90.9%).

Directors

According to the 2025 annual accounts

BRAFO BV

Director · represented by Lafaut Dieter

Also active at: Apotheek De Thems, BRAECKEVELT-LAFAUT, Debrafo

Shareholders

BRAFO

90.9%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Gistelse Steenweg 131

8200 Brugge

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Vereniging van Mede-eigenaars Appartementsgebouw Apotheek Sevrin Brugge(Sint-Andries) Gistelse Steenweg 131

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekdk.be

Canonical: https://www.apotheekdk.be/

Technologies

Contact Form 7Font AwesomeGoogle AnalyticsGoogle FontsLiteSpeedPHPWPBakeryWooCommerceWordPressYoast SEOjQuerylazysizes

Hosting & Email

Email provider

Self-hosted

Hosting

VOXILITY, GB

Website info

HTTPS Ja

Languages NL

Features

Webshop

Security

✓ HTTPS

✓ SPF

✓ DMARC

Network

✓ IPv6

Details

Company number

0426.771.294

VAT number

BE 0426.771.294

Registered office

Gistelse Steenweg 131, 8200 Brugge

Names & denominations

Apotheek DK

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

20 December 1984

Peppol

Active · Active since 13 Feb 2024

Contact

apotheekdk.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek DK

Financials

What happened to Apotheek DK?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions